PA
ATEC icon

PharVision Advisers’s Alphatec Holdings ATEC Stock Holding History

PharVision Advisers’s Portfolio ATEC Stock Details ATEC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,222
Closed -$166K – 69
2026
Q1 		$166K Buy
15,222
+3,043
+25% +$44.3K 1.68% 7
2025
Q4 		$256K Buy
+12,179
New +$225K 0.13% 379
2025
Q1 		– Sell
-21,895
Closed -$201K – 283
2024
Q4 		$201K Buy
+21,895
New +$175K 0.17% 308

Other funds holding ATEC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

PharVision Advisers's ATEC Position: Q2 2026 in Review

PharVision Advisers sold out of Alphatec Holdings (ATEC) in Q2 2026, closing a stake of 15,222 shares — an estimated $166K sold.

PharVision Advisers first reported a position in ATEC in Q4 2024 and held it in 3 quarters. The position peaked at $256K in Q4 2025. 267 funds tracked by Wall St. Rank hold ATEC as of Q2 2026.

  • PharVision Advisers reported no remaining Alphatec Holdings position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 15,222 Alphatec Holdings shares in Q2 2026, an estimated $166K.
  • PharVision Advisers first reported a position in Alphatec Holdings in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Alphatec Holdings position peaked at $256K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Alphatec Holdings as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.